Clincosm LogoSign in Get a demo

Advanced Cancer

Showing NaN - NaN of 27
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer, Metastatic Cancer, Solid Tumor Trial in United States (JZP815)

Recruiting
  • Advanced Cancer
  • +2 more
  • Denver, Colorado
  • +4 more
Jan 10, 2023

Metastatic Cancer, Solid Tumors, Advanced Cancer Trial in United States (ASP9801, Pembrolizumab)

Recruiting
  • Metastatic Cancer
  • +2 more
  • ASP9801
  • Pembrolizumab
  • Birmingham, Alabama
  • +26 more
Jan 6, 2023

Advanced Cancer Trial in Worldwide (Avelumab, Utomilumab, PF-04518600)

Active, not recruiting
  • Advanced Cancer
  • Encinitas, California
  • +87 more
Dec 7, 2022

Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer Trial in Worldwide (Ramucirumab, Merestinib, Cisplatin)

Active, not recruiting
Has Results
  • Biliary Tract Cancer
  • +2 more
  • Tucson, Arizona
  • +91 more
Oct 18, 2022

Advanced Cancer, Melanoma, NSCLC Trial in Worldwide (BMS-986205, Nivolumab, Ipilimumab)

Completed
  • Advanced Cancer
  • +2 more
  • Tucson, Arizona
  • +46 more
Aug 18, 2022

Advanced Cancer, Metastatic Cancer, Breast Cancer Trial in United Kingdom, United States (ART4215, Talazoparib, Niraparib)

Recruiting
  • Advanced Cancer
  • +2 more
  • Orlando, Florida
  • +6 more
Aug 16, 2022

Advanced Cancer, Metastatic Cancer, Ovarian Cancer Trial in United Kingdom, United States (ART0380, Gemcitabine, Irinotecan)

Recruiting
  • Advanced Cancer
  • +4 more
  • Denver, Colorado
  • +10 more
Jul 6, 2022

Solid Tumor, Metastatic Cancer, Advanced Cancer Trial in United States (GNX102)

Recruiting
  • Solid Tumor
  • +3 more
  • Los Angeles, California
  • +5 more
Mar 7, 2022

Advanced Cancer Trial in Worldwide (Ipilimumab, BMS-986218, Nivolumab)

Recruiting
  • Advanced Cancer
  • Ipilimumab
  • +2 more
  • Aurora, Colorado
  • +55 more
Mar 7, 2022

Advanced Cancer, Metastatic Cancer, Squamous Cell Carcinoma of Head and Neck Trial in United States (FS118)

Recruiting
  • Advanced Cancer
  • +2 more
  • Los Angeles, California
  • +6 more
Mar 3, 2022

Advanced Cancer Trial in Philadelphia (Interactive Music Therapy, Verbal support)

Completed
  • Advanced Cancer
  • Interactive Music Therapy
  • Verbal support
  • Philadelphia, Pennsylvania
  • +2 more
Feb 18, 2022

Carcinoma, Endometrial Adenocarcinoma, Tumors Trial in United States (PEN-866 Sodium, fluorouracil, Folinic acid)

Recruiting
  • Carcinoma
  • +18 more
  • PEN-866 Sodium
  • +3 more
  • Springdale, Arkansas
  • +15 more
Feb 16, 2022

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

Recruiting
  • Urothelial Carcinoma
  • +20 more
  • Gilbert, Arizona
  • +9 more
Feb 3, 2022

Advanced Cancer Trial in Worldwide (BMS-986178, Nivolumab, Ipilimumab)

Completed
Has Results
  • Advanced Cancer
  • Aurora, Colorado
  • +21 more
Dec 25, 2021

Advanced Cancer Trial in Worldwide (Nivolumab, Dasatinib, Relatlimab)

Terminated
Has Results
  • Advanced Cancer
  • Nivolumab
  • +4 more
  • Duarte, California
  • +49 more
Feb 23, 2021

Advanced Cancer Trial in Canada, United States (ARRY-334543, EGFR/ErbB2 inhibitor; oral)

Completed
  • Advanced Cancer
  • ARRY-334543, EGFR/ErbB2 inhibitor; oral
  • Philadelphia, Pennsylvania
  • +4 more
Oct 12, 2020

Advanced Cancer Trial in Aurora, Rochester, Philadelphia (ARRY-142886, MEK inhibitor; oral)

Completed
  • Advanced Cancer
  • ARRY-142886, MEK inhibitor; oral
  • Aurora, Colorado
  • +2 more
Oct 12, 2020

Advanced Cancer, Metastatic Cancer Trial in Canada, United States (LY3076226)

Completed
Has Results
  • Advanced Cancer
  • Metastatic Cancer
  • Philadelphia, Pennsylvania
  • +3 more
Apr 9, 2020

Advanced Cancer Trial in Canada, Korea, Republic of, United States (MGCD265)

Completed
  • Advanced Cancer
  • Duarte, California
  • +18 more
Feb 11, 2019

Advanced Cancer, Metastatic Cancer Trial in Albuquerque, Philadelphia (LY2523355, pegfilgrastim)

Completed
Has Results
  • Advanced Cancer
  • Metastatic Cancer
  • Albuquerque, New Mexico
  • +1 more
Aug 3, 2018

Pain, Advanced Cancer Trial in Worldwide (Nabiximols)

Completed
Has Results
  • Pain
  • Advanced Cancer
  • Phoenix, Arizona
  • +127 more
Mar 23, 2018

Pain, Advanced Cancer Trial in Worldwide (Nabiximols, Placebo (GA-0034))

Completed
Has Results
  • Pain
  • Advanced Cancer
  • Phoenix, Arizona
  • +71 more
Mar 23, 2018

Advanced Cancer Trial in United States (JNJ-61610588)

Terminated
  • Advanced Cancer
  • New York, New York
  • +3 more
Mar 26, 2018

Advanced Cancer Trial in United States (KTN3379)

Completed
  • Advanced Cancer
  • KTN3379
  • Denver, Colorado
  • +4 more
Jul 21, 2017

Advanced Cancer Trial in United States (LY2875358, LY2875358 + erlotinib, LY2875358 at Part A highest dose)

Completed
  • Advanced Cancer
  • La Jolla, California
  • +9 more
Feb 14, 2017